Expres2ion Biotech's IPO

Expres2ion Biotech raised a round of funding on June 30, 2016. Investors include Public.

ExpreS2ion Biotechnologies is a contract research organization within production in Drosophila Schneider-2 (S2) cells.…

Articles about Expres2ion Biotech's IPO: